Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Strides with Patented DehydraTECH™ Drug Delivery Platform
Lexaria Bioscience Corp. continues to make progress in the patenting and development of its DehydraTECH™ platform Lexaria developed the patented DehydraTECH™ drug delivery platform as a safer alternative to inhalation of nicotine or cannabinoids DehydraTECH™ has been shown to facilitate rapid uptake and highly targeted delivery of pharmaceuticals to the brain Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has levered innovation, research and development into operations in four market verticals: cannabis, hemp, nicotine, and pharmaceuticals. Lexaria already introduced the DehydraTECH™ drug delivery platform into commercial use and has a second-generation delivery platform ready for launch in 2020. Lexaria is the…